Search research articles
Contact Us
Filters
Showing results (1-10 of 9) with videos related to
Page
of 1
Sort By:
Nature Medicine
|
April 2, 2021
Do not sell regulatory science short
Jochen K Lennerz, Hetal D Marble, Laura Lasiter, et al.
JCO Oncology Practice
|
April 21, 2021
National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020
Richard Huang, Laura Lasiter, Adam Bard, et al.
Therapeutic Innovation & Regulatory Science
|
June 24, 2020
Use of Patient-Reported Outcomes to Understand & Measure the Patient Experience of Novel Cell and Gene Therapies
Laura Lasiter, Alicyn Campbell, Ethan Basch, et al.
American Health & Drug Benefits
|
July 24, 2020
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making
Madison M Wempe, Mark D Stewart, Daniel Glass, et al.
JCO Clinical Cancer Informatics
|
December 3, 2021
Comparing Findings From a Friends of Cancer Research Exploratory Analysis of Real-World End Points With the Cancer Analysis System in England
Pia Horvat, Christen M Gray, Alexandrina Lambova, et al.
Cytotherapy
|
March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancer
Mark D Stewart, Anne Keane, Lisa H Butterfield, et al.
Journal of Pathology Informatics
|
October 12, 2020
A Regulatory Science Initiative to Harmonize and Standardize Digital Pathology and Machine Learning Processes to Speed up Clinical Innovation to Patients
Hetal Desai Marble, Richard Huang, Sarah Nixon Dudgeon, et al.
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot
Laura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, et al.
Clinical Pharmacology and Therapeutics
|
October 19, 2021
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Donna R Rivera, Henry J Henk, Elizabeth Garrett-Mayer, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 9) with videos related to
Sort By:
Page
of 1
Nature Medicine
|
April 2, 2021
Do not sell regulatory science short
Jochen K Lennerz, Hetal D Marble, Laura Lasiter, et al.
JCO Oncology Practice
|
April 21, 2021
National Maintenance Cost for Precision Diagnostics Under the Verifying Accurate Leading-Edge In Vitro Clinical Test Development (VALID) Act of 2020
Richard Huang, Laura Lasiter, Adam Bard, et al.
Therapeutic Innovation & Regulatory Science
|
June 24, 2020
Use of Patient-Reported Outcomes to Understand & Measure the Patient Experience of Novel Cell and Gene Therapies
Laura Lasiter, Alicyn Campbell, Ethan Basch, et al.
American Health & Drug Benefits
|
July 24, 2020
A National Assessment of Diagnostic Test Use for Patients with Advanced NSCLC and Factors Influencing Physician Decision-Making
Madison M Wempe, Mark D Stewart, Daniel Glass, et al.
JCO Clinical Cancer Informatics
|
December 3, 2021
Comparing Findings From a Friends of Cancer Research Exploratory Analysis of Real-World End Points With the Cancer Analysis System in England
Pia Horvat, Christen M Gray, Alexandrina Lambova, et al.
Cytotherapy
|
March 23, 2020
Accelerating the development of innovative cellular therapy products for the treatment of cancer
Mark D Stewart, Anne Keane, Lisa H Butterfield, et al.
Journal of Pathology Informatics
|
October 12, 2020
A Regulatory Science Initiative to Harmonize and Standardize Digital Pathology and Machine Learning Processes to Speed up Clinical Innovation to Patients
Hetal Desai Marble, Richard Huang, Sarah Nixon Dudgeon, et al.
Clinical Pharmacology and Therapeutics
|
October 16, 2021
Real-world Overall Survival Using Oncology Electronic Health Record Data: Friends of Cancer Research Pilot
Laura Lasiter, Olga Tymejczyk, Elizabeth Garrett-Mayer, et al.
Clinical Pharmacology and Therapeutics
|
October 19, 2021
The Friends of Cancer Research Real-World Data Collaboration Pilot 2.0: Methodological Recommendations from Oncology Case Studies
Donna R Rivera, Henry J Henk, Elizabeth Garrett-Mayer, et al.
Page
of 1